Scholar Rock Holding (SRRK) Times Interest Earned (2024 - 2026)
Scholar Rock Holding (SRRK) posted quarterly Times Interest Earned of -$43.08 for Q1 2026, down 14.62% year-over-year from -$50.46 in Q1 2025, and down 33.84% quarter-over-quarter from -$32.19 in Q4 2025.
Analysis
Scholar Rock Holding (SRRK) Times Interest Earned (2024 - 2026) Analysis & Trends
Scholar Rock Holding's Times Interest Earned history runs 10 years deep, the most recent figure standing at -$43.08 for Q1 2026.
- In Q1 2026, Times Interest Earned fell 14.62% year-over-year to -$43.08; the TTM figure through Mar 2026 stood at -$46.08 (down 25.82% YoY), while the FY2025 annual figure was -$2.07, down 141.06% from the prior year.
- Times Interest Earned for Q1 2026 stood at -$43.08, down from -$32.19 in the prior quarter.
- The five-year high for Times Interest Earned was -$0.65 in Q3 2025, with the low at -$57.68 in Q2 2022.
- The 5-year median for Times Interest Earned is -$21.83 (2024), against an average of -$23.39.
- The sharpest annual moves came in 2022 and 2025: Times Interest Earned plunged 8814.95% in 2022, then surged 97.03% in 2025.
- Scholar Rock Holding's Times Interest Earned stood at -$24.24 in 2022, then rose by 0.67% to -$24.08 in 2023, then slumped by 78.48% to -$42.97 in 2024, then increased by 25.1% to -$32.19 in 2025, then plunged by 33.84% to -$43.08 in 2026.
- Business Quant data shows SRRK's Times Interest Earned at -$43.08 in Q1 2026, -$32.19 in Q4 2025, and -$0.65 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -493.00 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -21.24 |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 8.18 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 2.82 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 1.42 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.08 |
| 10 | Scholar Rock Holding | 7.24 Bn | 7.24 Bn | - | -24.10 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -24.10 |
| Mar 31, 2026 | -44.32 |
| Dec 31, 2025 | -36.27 |
| Sep 30, 2025 | -77.62 |
| Jun 30, 2025 | -92.96 |
| Mar 31, 2025 | -42.40 |
| Dec 31, 2024 | -42.14 |
| Sep 30, 2024 | -37.14 |
| Jun 30, 2024 | -34.69 |
| Mar 31, 2024 | -33.73 |